| Formulations of (s)-3-(1-(9h-purin-6-ylamino)ethyl)-8-chloro-2- … |
2022-3-21 |
2023-4-06 |
|
| Treatment of cancers using pi3 kinase isoform modulators |
2022-2-18 |
2022-5-24 |
|
| Solid forms of isoquinolinones, and process of making, composition comprising, … |
2022-1-18 |
2022-5-05 |
|
| Eganelisib for use in the treatment of pd-l1 negative cancer |
2021-12-07 |
2022-6-16 |
|
| CANCER INDUCTION USING PI3 KINASE ISOFORM MODIFIERS |
2021-11-12 |
2022-3-24 |
|
| Duvelisib |
2021-11-11 |
2021-11-11 |
|
| HETEROCYCLIC COMPOUNDS AND USES THEREOF |
2021-10-26 |
2023-1-05 |
|
| Combination therapies |
2021-9-14 |
2022-8-04 |
|
| Combination therapies |
2021-8-02 |
2022-4-28 |
|
| Methods of use of cyclopamine analogs |
2020-9-28 |
2021-9-09 |
|
| Heterocyclic compounds and uses thereof |
2020-3-11 |
2021-1-07 |
|
| PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES |
2019-12-19 |
2021-8-11 |
|
| Combination therapies |
2019-11-26 |
2020-10-29 |
|
| Treatment of cancers using pi3 kinase isoform modulators |
2019-9-24 |
2019-11-28 |
|
| Heterocyclic compounds and uses thereof |
2019-3-01 |
2019-10-31 |
|
| Isolation of cyclopamine |
2018-8-30 |
2019-8-29 |
|
| Methods of treating a fatty acid amide hydrolase-mediated condition |
2018-4-23 |
2018-8-30 |
|
| Heterocyclic compounds and uses thereof |
2017-6-07 |
2017-12-14 |
|
| Treatment of cancers using pi3 kinase isoform modulators |
2017-4-18 |
2018-1-04 |
|
| Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as … |
2017-3-16 |
2019-7-04 |
|
| Enzymatic transamination of cyclopamine analog |
2017-3-06 |
2017-8-03 |
|
| Heterocyclic compounds and uses thereof |
2016-10-25 |
2017-5-18 |
|
| Transfer hydrogenation of cyclopamine analogs |
2016-6-23 |
2018-1-30 |
2018-1-30 |
| Tetrazolones as inhibitors of fatty acid synthase |
2016-4-22 |
2017-5-04 |
|
| Compounds, compositions and methods for kinase modulation |
2016-4-07 |
2016-9-29 |
|
| Heterocyclic compounds and uses thereof |
2015-12-16 |
2016-7-21 |
|
| Processes for preparing isoquinolinones and solid forms of isoquinolinones |
2015-11-20 |
2015-12-10 |
|
| Treatment of rheumatoid arthritis and asthma using pi3 kinase inhibitors |
2015-10-06 |
2016-1-28 |
|
| Inhibitors of fatty acid amide hydrolase, methods of treatment and methods of … |
2015-8-17 |
2015-12-03 |
|
| Treatment of pulmonary or respiratory diseases by inhalation administration of … |
2015-5-19 |
2015-11-26 |
|
| Heterocyclic compounds and uses thereof |
2015-5-12 |
2015-9-03 |
|
| Pyrimidine or pyridine derivatives useful as pi3k inhibitors |
2015-4-28 |
2015-11-05 |
|
| Inhibitors of fatty acid amide hydrolase |
2015-1-16 |
2015-12-24 |
|
| Heterocyclic compounds and uses thereof |
2015-1-08 |
2017-8-01 |
2017-8-01 |
| Heterocyclic compounds and uses thereof |
2014-10-20 |
2016-8-25 |
|
| Heterocyclic compounds and uses thereof |
2014-10-10 |
2016-7-12 |
2016-7-12 |
| HETEROCYCLIC COMPOUNDS AND THEIR USES |
2014-10-03 |
2016-4-20 |
|
| Heterocyclic compounds and uses thereof |
2014-10-03 |
2015-4-09 |
|
| Heterocyclic compounds and uses thereof |
2014-10-03 |
2016-4-28 |
|
| Methods and compositions for identification, assessment and treatment of … |
2014-8-08 |
2015-1-22 |
|
| Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other … |
2014-7-31 |
2014-11-20 |
|
| Isoxazolines as inhibitors of fatty acid amide hydrolase |
2014-6-30 |
2015-4-09 |
|
| Treatment of cancers using P13 kinase isoform modulators |
2014-5-30 |
2021-4-30 |
|
| Treatment of cancers using pi3 kinase isoform modulators |
2014-5-30 |
2021-4-30 |
|
| Methods for stereoselective reduction |
2014-5-02 |
2016-1-19 |
2016-1-19 |
| Salts and solid forms of isoquinolinones and composition comprising and methods … |
2014-3-13 |
2016-11-01 |
2016-11-01 |
| Salts and solid forms of isoquinolinones and composition comprising and methods … |
2014-3-13 |
2017-4-28 |
|
| Heterocyclic compounds, selective inhibitors of class I pi3k isoforms; |
2014-2-28 |
2014-12-19 |
|
| Treatment of cancers using pi3 kinase isoform modulators |
2013-11-01 |
2015-10-08 |
|
| Inhibitors of fatty acid amide hydrolase |
2013-8-23 |
2013-12-26 |
|
| Inhibitors of fatty acid amide hydrolase |
2013-8-19 |
2013-12-19 |
|
| Triazoles as inhibitors of fatty acid synthase |
2013-4-29 |
2013-9-19 |
|
| Social Network Based Filtering of User Generated Content |
2013-3-12 |
2014-9-18 |
|
| Inhibitors of monoacylglycerol lipase and methods of their use |
2012-9-27 |
2017-4-25 |
2017-4-25 |
| Biomarkers predictive of therapeutic responsiveness to hsp90 inhibitors and … |
2012-8-23 |
2013-2-28 |
|
| Analogs of benzoquinone-containing ansamycins and methods of use thereof |
2012-8-20 |
2014-4-22 |
2014-4-22 |
| Cyclopamine analogue, and method of use thereof |
2012-7-24 |
2012-11-29 |
|
| heterocyclyl compounds and uses thereof |
2012-7-18 |
2017-6-13 |
|
| 1-oxo-isoquinolines and uses thereof |
2012-7-18 |
2016-7-01 |
|
| Heterocyclic compounds and uses thereof |
2012-7-18 |
2013-1-24 |
|
| Compounds and Methods for Inhibiting the Interaction of BCL Proteins with … |
2012-5-15 |
2013-5-23 |
|
| Oral formulations of a hedgehog pathway inhibitor, methods of producing the … |
2012-5-03 |
2012-6-28 |
|
| Ansamycin hydroquinone compositions |
2012-3-19 |
2012-8-24 |
|
| Isoxazolines as inhibitors of fatty acid amide hydrolase |
2011-11-24 |
2013-1-30 |
|
| Therapeutic regimens for hedgehog-associated cancers |
2011-7-08 |
2014-3-27 |
|
| Tetrazolones as inhibitors of fatty acid synthase |
2011-5-05 |
2011-12-16 |
|
| TETRAZOLONES AS INHIBITORS OF THE FATTY ACIDS SYNTHEASE |
2011-5-05 |
2013-3-13 |
|
| Treatment of fibrotic conditions using hedgehog inhibitors |
2011-1-14 |
2011-7-28 |
|
| Compounds and Methods for Inhibiting the Interaction of BCL Proteins with … |
2010-11-30 |
2011-6-30 |
|
| Methods and compositions for treating hedgehog-associated cancers |
2010-11-19 |
2012-6-14 |
|
| Compositions, kits, and methods for identification, assessment, prevention, and … |
2010-11-12 |
2011-5-19 |
|
| Compositions comprising a hedgehog inhibitor for use in extending cancer … |
2010-6-27 |
2010-12-30 |
|
| Methods Of Treating Liposarcoma |
2010-5-19 |
2012-5-03 |
|
| Isoxazolines as inhibitors of fatty acid amide hydrolase |
2010-5-18 |
2011-2-03 |
|
| Isoxazolines as inhibitors of fatty acid amide hydrolase |
2010-5-18 |
2011-2-03 |
|
| Anti-fatty acid amide hydrolase-2 antibodies and uses thereof |
2010-4-22 |
2015-6-23 |
2015-6-23 |
| Therapeutic Cancer Treatments |
2010-4-16 |
2010-11-25 |
|
| Compounds and Methods for Inhibiting the Interaction of BCL Proteins with … |
2010-4-02 |
2010-7-29 |
|